1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Global Infectious Disease Research Training (D43 Clinical Trial Optional) is sponsored by NIH Fogarty International Center. This program supports rigorous advanced research training programs for scientists from low- and middle-income countries (LMICs) focusing on infectious diseases that pose a potential threat to the U.S. and offer unique research opportunities not readily available domestically.
The training aims to strengthen collaborations between U.S. and LMIC researchers to better understand pathogen transmission and pathology, and to develop diagnostic, preventive, or treatment interventions suited for low-resource settings.
Get alerted about grants like this
Save a search for “NIH Fogarty International Center” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: U.S. institutions with demonstrated collaboration with a researcher at an LMIC institution, or foreign institutions in LMICs. Applicant institutions must have robust and high-quality research ongoing in the proposed areas. Confirm the full requirements in the official notice before applying.
Applications for Global Infectious Disease Research Training (D43 Clinical Trial Optional) are due August 6, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Global Infectious Disease Research Training (D43 Clinical Trial Optional) is funded by NIH Fogarty International Center. Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Start with the full solicitation document linked on this page — it contains the submission instructions and required forms.
Past winners and funding trends for this program
Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program (PA-26-085) is sponsored by NIH Fogarty International Center. This program funds collaborative health research projects between U.S. and Finnish universities. While not explicitly focused on traditional medicine or complementary health, research in global health could be part of the collaborative projects.
Global Infectious Diseases Research Training Program (D43 Clinical Trial Optional) is sponsored by NIH Fogarty International Center. This initiative supports rigorous advanced research training programs for low- and middle-income country (LMIC) scientists on infectious diseases that pose a potential threat to the U.S. and present special opportunities for research not readily available in the U.S. Programs will provide long-term research training, mentorship, and training in data-driven science, professional skills, responsible conduct of research, and biosafety. Trainee research projects will leverage NIH-funded studies to enhance NIH international investments and strengthen collaborations between U.S. and LMIC researchers to better understand pathogen transmission and pathology, and to develop diagnostic, preventive, or treatment interventions suited to low-resource settings globally.
NIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read articleNIH committed $402 million across 601 multiyear-funded grants in the first eight months of FY 2026 — more than four times the pace of two years ago. The mechanism front-loads obligations into a single fiscal year, leaving less budget for new project starts and squeezing FY 2026 success rates. What researchers and institutions should be doing now.
Read articlePAR-26-042 funds NLM-priority clinical informatics R01 grants up to $250,000 in direct costs per year through March 6, 2029, with standard NIH cycles on October 5, February 5, and June 5. The notice explicitly defines non-responsive applications: incremental tool improvements, projects primarily focused on social determinants of health, and projects primarily focused on ethical/legal/social issues. With NIH SBIR/STTR just reopened and the OMB Uniform Grants Regulation rewrite reshaping discretionary awards, the NLM clinical informatics line is one of the few stable, well-defined biomedical funding streams left at the agency. Here is how to read it.
Read article